Baker Brothers Advisors - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAD3. A total of 7 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q1 2017$95,967,000
+6.0%
22,379,0000.0%0.78%
-11.5%
Q4 2016$90,531,000
-10.7%
22,379,0000.0%0.89%
-3.6%
Q3 2016$101,405,000
+19.4%
22,379,0000.0%0.92%
+3.4%
Q2 2016$84,908,000
-5.5%
22,379,0000.0%0.89%
-6.0%
Q1 2016$89,825,000
-22.0%
22,379,0000.0%0.95%
-0.7%
Q4 2015$115,158,000
-0.4%
22,379,0000.0%0.95%
-10.7%
Q3 2015$115,619,000
-22.9%
22,379,0000.0%1.07%
-18.8%
Q2 2015$149,970,000
+9.5%
22,379,0000.0%1.32%
+15.5%
Q1 2015$136,987,000
+34.2%
22,379,000
-2.3%
1.14%
+9.3%
Q4 2014$102,104,000
+25.5%
22,898,0000.0%1.04%
+1.7%
Q3 2014$81,355,000
+15.4%
22,898,0000.0%1.02%
+18.6%
Q2 2014$70,511,000
-8.6%
22,898,0000.0%0.86%
-11.8%
Q1 2014$77,127,000
-2.8%
22,898,0000.0%0.98%
-12.4%
Q4 2013$79,367,000
-3.2%
22,898,0000.0%1.12%
-4.0%
Q3 2013$82,032,000
+29.8%
22,898,0000.0%1.17%
-6.7%
Q2 2013$63,217,00022,898,0001.25%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q2 2016
NameSharesValueWeighting ↓
Amici Capital, LLC 8,000,000$35,720,0001.61%
Baker Brothers Advisors 22,898,000$102,104,0001.04%
CITIGROUP INC 6,176,000$27,560,0000.02%
SG Americas Securities, LLC 10,000$4,465,0000.02%
SSI INVESTMENT MANAGEMENT LLC 37,000$165,0000.02%
GEODE CAPITAL MANAGEMENT, LLC 1,000,000$4,462,0000.00%
Allianz Asset Management GmbH 300,000$1,340,0000.00%
UBS Group AG 22,000$98,0000.00%
ROYAL BANK OF CANADA 2,000$8,0000.00%
MORGAN STANLEY 11,000$49,0000.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders